Financial News

Financial Report: Thermo Fisher Scientific

Life Sciences Solutions Segment revenue up 9% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fisher Scientific 2Q Revenues: $6.3 billion(+4%) 2Q Earnings: $1.1 billion (+49%) YTD Revenues: $12.4 billion (+4%) YTD Earnings: $1.9 billion (+45%) Comments: The Life Sciences Solutions Segment revenue was up 9% to $1.7 billion in the quarter. Analytical Instruments Segment revenue grew 1% to $1.3 billion. Specialty Diagnostics Segment revenue increased 1% to $0.94 billion. Laboratory Products and Services Segment revenue grew 3% to $2.6 billion. Reported results in 2019 and 2018 i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters